Medpace
MEDP
113 hedge funds and large institutions have $311M invested in Medpace in 2017 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 41 increasing their positions, 20 reducing their positions, and 10 closing their positions.
270% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 10
105% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 20
52% more capital invested
Capital invested by funds: $204M → $311M (+$107M)
31% more funds holding
Funds holding: 86 → 113 (+27)
6.09% more ownership
Funds ownership: 16.2% → 22.29% (+6.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$22.7M |
| 2 |
CCMLC
Cardinal Capital Management LLC (Connecticut)
Greenwich,
Connecticut
|
+$8.32M |
| 3 |
MWNA
Marshall Wace North America
New York
|
+$7.34M |
| 4 |
Two Sigma Investments
New York
|
+$5.86M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$15.9M |
| 2 |
Millennium Management
New York
|
-$2.87M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.57M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$1.62M |
| 5 |
SIM
Spark Investment Management
New York
|
-$1.06M |
MEDP Hedge Fund Activity: Q4 2017 in Review
113 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q4 2017, worth a combined $311M — up 52% from $204M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new MEDP positions and 10 closed out — a net gain of 27 holders — while 41 added to existing stakes and 20 trimmed.
The largest buyer was BlackRock, adding an estimated $22.7M. The largest seller was Redmile Group, exiting entirely with an estimated $15.9M sold.
- 113 institutional investors held Medpace (MEDP) as of Q4 2017, up from 86 in Q3 2017.
- Funds reported $311M of Medpace stock for Q4 2017, up 52% quarter-over-quarter.
- 37 funds opened new Medpace positions in Q4 2017 and 10 closed out, a net change of +27 holders.
- The largest Medpace buyer in Q4 2017 was BlackRock, an estimated $22.7M added.
- The largest Medpace seller in Q4 2017 was Redmile Group, an estimated $15.9M sold.
Based on aggregated 13F filings for Q4 2017.